132 related articles for article (PubMed ID: 32953488)
1. Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients.
Tamminga M; Oomens L; Hiltermann TJN; Andree KC; Tibbe A; Broekmaat J; Schuuring E; Terstappen LWMM; Groen HJM
Transl Lung Cancer Res; 2020 Aug; 9(4):1093-1100. PubMed ID: 32953488
[TBL] [Abstract][Full Text] [Related]
2. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
[TBL] [Abstract][Full Text] [Related]
3. Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
Andree KC; Mentink A; Zeune LL; Terstappen LWMM; Stoecklein NH; Neves RP; Driemel C; Lampignano R; Yang L; Neubauer H; Fehm T; Fischer JC; Rossi E; Manicone M; Basso U; Marson P; Zamarchi R; Loriot Y; Lapierre V; Faugeroux V; Oulhen M; Farace F; Fowler G; Sousa Fontes M; Ebbs B; Lambros M; Crespo M; Flohr P; de Bono JS
Int J Cancer; 2018 Nov; 143(10):2584-2591. PubMed ID: 30006930
[TBL] [Abstract][Full Text] [Related]
4. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
Fehm TN; Meier-Stiegen F; Driemel C; Jäger B; Reinhardt F; Naskou J; Franken A; Neubauer H; Neves RPL; van Dalum G; Ruckhäberle E; Niederacher D; Rox JM; Fischer JC; Stoecklein NH
Cytometry A; 2018 Dec; 93(12):1213-1219. PubMed ID: 30551262
[TBL] [Abstract][Full Text] [Related]
6. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
[TBL] [Abstract][Full Text] [Related]
7. StarDist Image Segmentation Improves Circulating Tumor Cell Detection.
Stevens M; Nanou A; Terstappen LWMM; Driemel C; Stoecklein NH; Coumans FAW
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740582
[TBL] [Abstract][Full Text] [Related]
8. Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.
Stevens M; Mentink A; Nanou A; Coumans FAW; Isebia KT; Kraan J; Hamberg P; Martens JWM; Terstappen LWMM
Cytometry A; 2023 Nov; 103(11):881-888. PubMed ID: 37461156
[TBL] [Abstract][Full Text] [Related]
9. Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.
Stevens M; Mentink A; Coumans FAW; Dathathri E; Isebia KT; Kraan J; de Wit R; Martens JWM; Terstappen LWMM
Mol Oncol; 2023 Dec; ():. PubMed ID: 38073130
[TBL] [Abstract][Full Text] [Related]
10. Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products.
Guglielmi R; Lai Z; Raba K; van Dalum G; Wu J; Behrens B; Bhagat AAS; Knoefel WT; Neves RPL; Stoecklein NH
Sci Rep; 2020 Nov; 10(1):20312. PubMed ID: 33219265
[TBL] [Abstract][Full Text] [Related]
11. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
[TBL] [Abstract][Full Text] [Related]
12. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
13. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
14. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
16. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).
Papadaki MA; Messaritakis I; Fiste O; Souglakos J; Politaki E; Kotsakis A; Georgoulias V; Mavroudis D; Agelaki S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477700
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.
Sawada T; Araki J; Yamashita T; Masubuchi M; Chiyoda T; Yunokawa M; Hoshi K; Tao S; Yamamura S; Yatsushiro S; Abe K; Kataoka M; Shimoyama T; Maeda Y; Kuroi K; Tamura K; Sawazumi T; Minami H; Suda Y; Koizumi F
EBioMedicine; 2016 Sep; 11():173-182. PubMed ID: 27495793
[TBL] [Abstract][Full Text] [Related]
19. Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.
Nanou A; Crespo M; Flohr P; De Bono JS; Terstappen LWMM
Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30384500
[TBL] [Abstract][Full Text] [Related]
20. Filter characteristics influencing circulating tumor cell enrichment from whole blood.
Coumans FA; van Dalum G; Beck M; Terstappen LW
PLoS One; 2013; 8(4):e61770. PubMed ID: 23626725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]